Revolutionizing Biomedical Imaging with AI and Open-Source Tools
Innovative open-source tools powered by AI are transforming biomedical imaging by making fluorescence lifetime imaging microscopy faster, more accessible, and more precise for live biological research.
Recent advancements in biomedical imaging have been significantly propelled by the integration of artificial intelligence (AI) and open-source software. A breakthrough development by Ph.D. student Sofia Kapsiani from the Molecular Neuroscience Group at the University of Cambridge has introduced innovative tools that make fluorescence lifetime imaging microscopy (FLIM) faster, more accessible, and cost-effective. These tools address longstanding challenges related to imaging speed, data analysis complexity, and high costs associated with traditional closed-source software.
Kapsiani has developed two complementary open-source solutions: FLIMPA, a versatile software for phasor analysis, and FLIMngo, a deep learning model designed to drastically reduce data acquisition time. Together, they enable researchers to perform high-throughput and real-time FLIM, which is crucial for live imaging in biological and medical research. The deployment of FLIMngo, trained on minimal photon data, allows for rapid in vivo image analysis in just seconds without compromising accuracy. This significantly minimizes light exposure and phototoxicity, essential factors when working with live specimens.
The impact of these tools extends beyond speed. FLIMngo opens new avenues for live diagnostics and dynamic studies, such as tracking disease-related proteins in living organisms like C. elegans. Its open-source nature ensures wide accessibility and adaptability across various imaging systems.
In addition, the earlier software, FLIMPA, provides a user-friendly platform for phasor analysis, supporting the interpretation of complex FLIM data. Its compatibility with multiple file formats and advanced visualization features have made it a valuable resource for both research and clinical applications, including the development of assays for cancer drug research.
These advancements mark a transformative step in biomedical imaging, empowering researchers and healthcare professionals to perform more efficient, detailed, and non-invasive studies. By removing barriers related to cost and technical complexity, AI and open-source solutions are set to accelerate discovery and improve patient care.
Source: https://medicalxpress.com/news/2025-07-ai-source-software-faster-easier.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Empowering RMD Patients Through Education: The Role of Patient Organizations
Patient organizations play a crucial role in educating and supporting individuals with rheumatic musculoskeletal diseases, offering resources on disease management and addressing sensitive topics like sexual health.
Gabapentin Use Linked to Increased Risk of Cognitive Impairment and Dementia
Recent research indicates that prolonged gabapentin use may significantly increase the risk of dementia and cognitive impairment, especially in younger adults. Learn the details in our latest report.
Gut Microbiota as a Non-Invasive, Cost-Effective Screening Approach for Colorectal Cancer
New research explores how analyzing gut bacteria can serve as a non-invasive, low-cost method for early detection of colorectal cancer, potentially transforming screening practices.
How Biological Sex Influences Immune Responses and Disease Risks
Understanding how biological sex influences immune responses provides crucial insights into disease susceptibility and personalized medicine. Discover the latest research from La Jolla Institute on sex differences in immunity and disease risks.